Nobaxin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nobaxin

Property Description
Active ingredient Azithromycin
Form Tablets, Capsules, Oral Suspension
Pharmacological class Macrolide Antibiotic (Azalide)
Common use Systemic Bacterial Infection Treatment
Origin Semi-synthetic

What Type of Medicine is Nobaxin (Azithromycin)?

Nobaxin is a prescription-only medicine (POM) that serves as a broad-spectrum antibiotic, specifically belonging to the macrolide antibiotic class. Its identity is defined by its active ingredient, Azithromycin. Azithromycin is an azalide, a subclass of macrolides with specific structural characteristics.

This pharmaceutical preparation is classified more precisely as an azalide, differentiated by a nitrogen atom incorporated into its chemical structure. This particular modification confers a longer tissue half-life, which impacts the dosing frequency compared to earlier macrolides. As an antimicrobial drug, its fundamental purpose is the systemic infection treatment of illnesses caused by susceptible bacteria throughout the body.


Composition and Pharmaceutical Forms of Nobaxin

The core of Nobaxin is the single-ingredient product, Azithromycin, a compound derived from a semi-synthetic process. For oral route of administration, the drug is available in several common dosage forms, including tablets, capsules, and oral suspension.

These various pharmaceutical preparations ensure flexible delivery to different patient groups, such as adults and pediatric patients. For instance, the liquid oral suspension form, often focused on the younger patient group, provides a distinct advantage in administration. The composition focuses on the Azithromycin tri-hydrate salt, which is combined with necessary pharmaceutical excipients to create the stable and absorbable final product.


High-Level Purpose and Mechanism Principle

The general purpose of Nobaxin is to achieve bacterial eradication by directly stopping the growth of the infecting organisms. It works by interfering with the bacteria's critical process of making essential proteins.

Azithromycin achieves this by binding to a specific part of the bacterial machinery (the ribosome), preventing it from assembling proteins required for survival. This mechanism principle of protein synthesis inhibition results in effective control over the bacterial load, ensuring that the patient's body can clear the underlying cause of illness.

Regulatory References

  1. Azithromycin: MedlinePlus Drug Information

What side effects are possible with Nobaxin?

Possible Side Effects and Safety Information

The safety profile of Nobaxin (Azithromycin) is categorized in regulatory documents based on the frequency and system-organ class of documented adverse reactions. The most frequent reactions are primarily associated with the Gastrointestinal Disorders system.


Official Classification of Common Adverse Reactions

Adverse reactions are grouped into categories reflecting their likelihood, as defined in official regulatory labeling:

  • Very Common: Diarrhea, abdominal pain, nausea, flatulence, abdominal discomfort, and loose stools.
  • Common: Dizziness, headache, paraesthesia, dysgeusia (altered taste), visual impairment, deafness, rash, pruritus (itching), arthralgia, and fatigue.

Less common effects, such as palpitations, hepatitis, and photosensitivity reaction, are also officially documented.


Documented Serious Adverse Reactions

Regulatory warnings explicitly highlight potential serious reactions, including risks to the cardiovascular system and the liver.

  • Cardiovascular Safety: The medication is associated with the potential for QT interval prolongation, which carries a risk for severe heart rhythm irregularities, such as Torsades de pointes and ventricular arrhythmia. This risk requires caution, particularly in older adults.
  • Hepatotoxicity: Reports include severe liver injury, ranging from hepatitis to hepatic failure. The use of Azithromycin is contraindicated in individuals with a known history of cholestatic jaundice or liver dysfunction associated with prior use of the drug.
  • Hypersensitivity: Rare, severe allergic reactions are documented, including Anaphylaxis and severe cutaneous adverse reactions (SCARs) like Stevens-Johnson Syndrome (SJS).

Population- and Time-Specific Safety Notes

The official label notes specific considerations for certain groups: caution is advised for patients with severe renal impairment and for neonates (up to 42 days of life) due to the reported risk of Infantile Hypertrophic Pyloric Stenosis (IHPS). Furthermore, due to the drug’s prolonged presence in tissue, allergic symptoms may reappear following symptomatic treatment, and C. difficile-Associated Diarrhea can occur up to two months after administration.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information addresses the management of taking doses of Nobaxin higher than those recommended. In the event of an overdose, a specific set of severe symptoms and actions are documented in the authorized labeling.

Documented Overdose Presentations

Symptoms associated with an overdosage are generally described as severe but reversible. These presentations primarily involve the auditory and gastrointestinal systems:

  • Reversible Loss of Hearing: A temporary impairment or loss of hearing has been documented as a severe manifestation of overdosage.
  • Severe Gastrointestinal Symptoms: This includes pronounced effects such as nausea, vomiting, and diarrhea.

Emergency Actions Required

In the case of a suspected or confirmed overdosage, urgent medical attention must be sought immediately. The emergency management of an overdose is symptomatic and supportive, with procedural instructions for healthcare providers including:

  • Gastric Lavage and Supportive Care: General measures to maintain vital functions are indicated.
  • Activated Charcoal: Administration of activated charcoal may be considered to help reduce the drug's absorption.

No specific pharmacologic antidote is designated for Nobaxin overdosage. The primary goal of management is to stabilize the patient and support them through the period of acute toxicity.

Therapeutic Uses of Nobaxin

Nobaxin: Main Uses and Benefits

Nobaxin contains the active substance azithromycin, which is indicated for the treatment of specific bacterial infections. Its primary applications focus on infections caused by microorganisms that are sensitive to this agent.


Key Therapeutic Uses

The medication is used to manage a range of infections, including specific lower respiratory tract infections, such as acute bronchitis and the exacerbation of chronic bronchitis, as well as certain types of community-acquired pneumonia.

Nobaxin is also utilized in the treatment of various skin and soft tissue infections, including conditions like impetigo and secondary infected dermatitis. Furthermore, it is indicated for treating specific sexually transmitted diseases, such as uncomplicated infections caused by Chlamydia trachomatis.


Quick Facts

  • Treats acute bronchitis and exacerbation of chronic bronchitis.
  • Manages specific community-acquired pneumonia.
  • Indicated for skin and soft tissue infections like impetigo.
  • Used for uncomplicated Chlamydia trachomatis infections.

Eligibility and Restrictions for Use

Nobaxin, which contains the active substance Nimesulide, is an anti-inflammatory medicine whose use is strictly governed by governmental regulatory restrictions, primarily due to concerns related to liver safety. The medicine is authorized for use only in adolescents aged 12 years and older and adults.

Populations Who Must Not Use Nobaxin (Contraindicated)

Official regulatory documents explicitly contraindicate the use of this medicine in several patient groups:

  • Age Restrictions: Children under 12 years of age.
  • Liver Function: Patients with any form of hepatic impairment (liver failure) or a history of hepatotoxic reactions to Nimesulide.
  • Gastrointestinal and Coagulation: Patients with active gastrointestinal ulceration or bleeding, a history of recurrent ulcers, or severe coagulation disorders.
  • Cardiovascular and Renal Function: Individuals with severe heart failure or severe renal impairment (kidney function impairment).
  • Reproductive Status: Women in the third trimester of pregnancy and those who are breastfeeding.

Additionally, use is not recommended for patients who have an allergy to aspirin or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or those with a history of alcohol or drug abuse, as these factors may increase risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Azithromycin (Nobaxin) documents several interaction patterns, including those formally prohibited and those requiring specific administration timing.

Official Restrictions and Contraindications

  • Ergot Derivatives: The co-administration of Azithromycin with Ergotamine or Dihydroergotamine is formally contraindicated (prohibited) due to the theoretical risk of ergotism, a condition known to be precipitated by combination with other macrolide antibiotics.

  • QT-Prolonging Agents: Caution is required when combining Nobaxin with other QT-prolonging drugs (e.g., Amiodarone), as the combination presents an additive pharmacodynamic risk of serious cardiac arrhythmias, specifically Torsades de Pointes.

  • Anticoagulants: Post-marketing reports document that co-administration with Coumarin-type oral anticoagulants (e.g., Warfarin) may potentiate anticoagulation, often requiring monitoring of coagulation times.

Pharmacokinetic and Transporter Interactions

Nobaxin acts as a P-glycoprotein (P-gp) inhibitor, a mechanism documented to increase the exposure of co-administered P-gp substrates, such as Digoxin and Colchicine. Additionally, the co-administration of the HIV protease inhibitor Nelfinavir is known to increase Azithromycin's maximum plasma concentration and overall exposure.

Timing and Food Requirements

  • Antacids: Aluminum- or Magnesium Hydroxide-containing antacids are documented to reduce Azithromycin's peak concentration (Cmax). To prevent this effect, oral Azithromycin must be administered at least two hours apart from these antacids.

  • Food: Ingesting the tablet or suspension formulation with food may increase the peak concentration of Azithromycin, though it does not significantly change the total overall exposure (AUC).

Mechanism of Action

Inhibiting Bacterial Protein Production

Nobaxin (Azithromycin) operates via direct inhibition of susceptible bacteria. Its mechanism focuses on the molecular target within the bacterial cell: the 50S ribosomal subunit. The molecule binds to the 23S ribosomal RNA (rRNA) and physically obstructs the nascent peptide exit tunnel, which is critical for translation. This interruption halts the synthesis of essential bacterial proteins, effectively achieving bacteriostasis by preventing the growth and replication of the bacteria.

Modulating Host Inflammation and Targeted Concentration

Beyond antimicrobial action, the molecule engages secondary mechanisms to modulate host physiological systems. It accumulates highly within immune cells like phagocytes, enhancing its distribution. Furthermore, the molecule suppresses the activity of pathways such as NF-kappaB, thereby reducing the release of pro-inflammatory cytokines (e.g., IL-8) and resulting in a reduction of inflammatory signaling and mediator release.

Dosage and Administration Information

Nobaxin (Azithromycin) is administered in specific ways to ensure proper delivery. The approved routes are Oral (tablets, capsules, or suspension) and Intravenous (IV) for initial therapy in certain conditions.


Official Dosing and Scheduling

Administration is a single dose per day for the total duration of the course. Standard adult usage patterns include:

  • Single-Dose Course: 1000 mg as a single oral dose.
  • 3-Day Course: 500 mg once daily for 3 consecutive days.
  • 5-Day Course: 500 mg on the first day, followed by 250 mg once daily on Days 2 through 5.

Oral tablets and suspensions may be taken with or without food.


Administration Requirements

IV Administration: The lyophilized powder must be reconstituted and diluted prior to use. The resulting solution is administered as an infusion over a minimum duration of 60 minutes; it is not given as an IV bolus or intramuscular injection.

Pediatric Patients: Dosing for children is weight-based (mg/kg) for a 3-day or 5-day course. For adults with mild to moderate renal or hepatic impairment, no dose adjustment is typically required.

In the event of a missed dose, if 12 hours or less have passed, the dose is taken and the original schedule is continued. If more than 12 hours have passed, the next dose is taken at the regularly scheduled time.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nobaxin


Evidence for Use in Community-Acquired Pneumonia (CAP)

Research into Nobaxin (Azithromycin) for Community-Acquired Pneumonia primarily involves Randomized Controlled Trials (RCTs) and systematic regulatory reviews. These studies was evaluated in research contexts involving systemic or functional imbalance. The studies monitored clinical endpoints such as resolution of symptoms or treatment failure at defined post-treatment intervals. High-level endpoints such as hospitalization and patient status were among the outcomes that research examined. While extensive research exists, some older trials were open-label, which may introduce limitations in the interpretation of some findings.


Evidence for Use in Acute Exacerbation of Chronic Bronchitis (AECB)

Nobaxin was evaluated in studies for conditions involving periods of heightened symptoms. The available evidence comes from RCTs that were conducted during periods of increased symptom activity. Research examined outcomes related to episodic symptom patterns, such as resolution of acute changes related to the exacerbation. Some trials evaluated treatment failure rates in specific subgroups, and the data suggests patterns related to different outcomes when compared to certain other agents. A key limitation is that many studies relied on non-inferiority designs, focusing on whether the drug was not substantially worse than a comparator.


What is Still Uncertain About Nobaxin's Research

Research for certain populations remains insufficient, particularly for pregnant women or those with significant comorbidities. The evidence quality varies across studies, and follow-up durations were limited in many acute infection studies, meaning there is limited information for long-term outcomes after the initial recovery. Additionally, subgroup findings are uncertain in some cases, and research is ongoing to better contextualize the findings from these studies.

Frequently Asked Questions (FAQ)

Common questions about Nobaxin (FAQ)


Q: Can Nobaxin be taken by people who are sensitive to penicillin?

Official information describes Nobaxin (azithromycin) as a macrolide antibiotic, which belongs to a different chemical class than penicillin. Because the drug classes are distinct, a cross-reaction between the two is generally not expected based on established regulatory principles.


Q: How quickly does Nobaxin typically start to work?

Official information does not provide a specific time frame for when symptom relief may begin, as this can vary by infection. However, the medicine's properties, such as its rapid distribution into the body's tissues, are noted in pharmacological studies. This characteristic is relevant to its action against susceptible bacteria.


Q: Does Nobaxin cause drowsiness or make you feel dizzy?

Regulatory documents list dizziness as a common side effect. Drowsiness is generally not listed among the most frequent adverse reactions. Official product information notes that the ability to drive or operate machinery may be impaired if a person experiences dizziness or other coordination-related side effects.


Q: What is the difference between Nobaxin and Brand X (a similar drug)?

Nobaxin (azithromycin) is classified as an azalide, a distinct subclass of macrolide antibiotics. This classification relates to its specific chemical structure, which regulatory documents note gives it unique properties. These properties include a prolonged presence in tissue, which is associated with its once-daily dosing frequency.


Q: Is Nobaxin habit-forming or addictive?

Nobaxin is an antibiotic used to treat bacterial infections. According to regulatory agencies, the medicine is not classified as a controlled substance and has no known potential for abuse, dependence, or addiction.


Q: Can I take Nobaxin if I have a history of stomach ulcers?

Regulatory documents describe the medicine as contraindicated (not permitted) for patients who have active gastrointestinal ulceration, bleeding, or a history of recurrent ulcers. Official documents note that the use of this medicine in a patient with a non-recurrent or prior history should be assessed against the potential risks.


Q: Is it possible to be allergic to Nobaxin?

Yes, severe allergic reactions (hypersensitivity) are documented in the official safety profile. Nobaxin is contraindicated in patients with a known allergy to azithromycin or any other macrolide or ketolide antibiotic. Rare, serious allergic reactions, including anaphylaxis, have been reported.


Q: Is it necessary to finish the entire course of Nobaxin if I feel better quickly?

Patient information supported by regulatory bodies indicates that the treatment is intended to be completed. This practice is generally emphasized to support the clearance of the infection and to minimize the potential for drug-resistant bacteria to develop, as noted in authoritative sources.


Q: What is the official recommended time of day to take Nobaxin?

The official instructions specify that Nobaxin should be taken as a single dose per day. The single-dose-per-day regimen requires taking the dose at approximately the same time each day to help maintain consistent medicine levels, and it can be taken with or without food.


Q: What is the general classification of the Nobaxin drug?

Nobaxin (azithromycin) is a prescription-only medicine (POM). It belongs to the macrolide antibacterial drug class, specifically categorized as an azalide.


Q: Is Nobaxin available over the counter?

Nobaxin (azithromycin) is classified as a prescription-only medicine in most regulatory jurisdictions. It is not available for purchase over the counter for the treatment of systemic bacterial infections.


Q: Are there any specific safety facts about Nobaxin for women who might be pregnant?

The medicine is contraindicated during the third trimester of pregnancy. Research evidence is limited for use during the earlier stages of pregnancy. Official product information notes that use in women of childbearing potential involves an assessment of the potential benefits compared to the potential risks.


Q: Are there known interactions between Nobaxin and herbal supplements?

Official interaction documents primarily focus on pharmaceutical drugs. Official regulatory guidance emphasizes that all concomitant products, including herbal remedies, vitamins, or supplements, are relevant when reviewing prescription medicines, as they are often not formally tested for interactions.


Q: Does Nobaxin require a special diet?

Nobaxin (azithromycin) tablets and suspension do not require a special diet and can be taken with or without food. However, regulatory instructions mandate a separation of at least two hours if taking aluminum- or magnesium hydroxide-containing antacids.


Q: Can Nobaxin be crushed or split?

Tablets are typically required to be swallowed whole unless regulatory instructions or a healthcare provider specifically authorizes an alternative method. Crushing or splitting unscored tablets is usually not recommended to ensure the full, accurate dose is administered.


Q: Can Nobaxin be taken with dairy products?

Nobaxin tablets and suspension can be taken with or without food. Regulatory documents do not list dairy products as a specific substance requiring separation or avoidance, unlike certain other antibiotic classes.


Q: Are weight changes a possible side effect of Nobaxin?

Weight change is not listed as a Very Common or Common adverse reaction in the official safety profile of Nobaxin (azithromycin). The most frequent side effects are related to the gastrointestinal system.


Q: Is there a generic version of Nobaxin available?

The active ingredient in Nobaxin is azithromycin, which is the generic name for the medicine. Azithromycin is widely available in generic formulations from various manufacturers, in addition to the brand-name product.


Q: What types of research studies have been conducted on Nobaxin?

Research supporting Nobaxin includes Randomized Controlled Trials (RCTs), which assess clinical outcomes. Additionally, pharmacokinetic studies are conducted to measure the drug's properties, such as how it is absorbed and its concentration in the body's tissues over time.


Q: Can Nobaxin be taken with other types of pain relievers?

Official warnings specifically list interactions with certain cardiovascular medicines and ergot derivatives. The labels do not list common over-the-counter pain relievers like acetaminophen or standard NSAIDs as a formal restriction, though all co-administration should be reviewed against official warnings.

How should Nobaxin be stored and disposed of?

How to Store and Dispose of Nobaxin?

The storage of Nobaxin (azithromycin) must strictly follow official regulatory requirements to ensure the product remains stable.

Storage Conditions

Nobaxin tablets and capsules must be stored in their original container at controlled room temperature, typically between 20 C and 25 C. They must be protected from excessive moisture and light. The medicine must be kept out of the sight and reach of children.

Stability and Handling

The dry powder for oral suspension is stored below 30 C before preparation. Once mixed, the liquid suspension has a limited shelf-life and must be discarded after a specific period, often 10 days, and must not be frozen.

Disposal

Unused or expired Nobaxin should be disposed of through a community drug take-back program. If a program is unavailable, follow the official guidance to render the medicine unusable (e.g., mixing with undesirable substances) before placing it in the trash. Unused product must not be disposed of via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nobaxin found in:

A-Z Index: